Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Ruzicka

Showing results (551-560 of 564) with videos related to

Pageof 57
Sort By:
The British Journal of Dermatology|August 18, 2009
A randomized controlled trial of R-salbutamol for topical treatment of discoid lupus erythematosusG B E Jemec, S Ullman, M Goodfield, et al.
American Journal of Human Genetics|June 23, 1998
Muir-Torre phenotype has a frequency of DNA mismatch-repair-gene mutations similar to that in hereditary nonpolyposis colorectal cancer families defined by the Amsterdam criteriaR Kruse, A Rütten, C Lamberti, et al.
The British Journal of Dermatology|March 13, 2010
Systematic mutation screening of KRT5 supports the hypothesis that Galli-Galli disease is a variant of Dowling-Degos diseaseS Hanneken, A Rütten, S M Pasternack, et al.
The British Journal of Dermatology|November 30, 2018
Association of pyrin mutations and autoinflammation with complex phenotype hidradenitis suppurativa: a case-control studyS Vural, M Gündoğdu, E Gökpınar İli, et al.
The Journal of Investigative Dermatology|December 14, 1999
Novel Hairless mutations in two kindreds with autosomal recessive papular atrichiaR Kruse, S Cichon, M Anker, et al.
Arthritis and Rheumatism|May 29, 2007
Low number of regulatory T cells in skin lesions of patients with cutaneous lupus erythematosusB Franz, B Fritzsching, A Riehl, et al.
The British Journal of Dermatology|October 13, 2006
Multicentre, phase II trial on the safety and efficacy of topical tacrolimus ointment for the treatment of lichen sclerosusU R Hengge, W Krause, H Hofmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2000
Cutting edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ALP/ILC)B Homey, W Wang, H Soto, et al.
The British Journal of Dermatology|September 27, 2015
The first trial of CIM331, a humanized antihuman interleukin-31 receptor A antibody, in healthy volunteers and patients with atopic dermatitis to evaluate safety, tolerability and pharmacokinetics of a single dose in a randomized, double-blind, placebo-controlled studyO Nemoto, M Furue, H Nakagawa, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 18, 2020
European S1 guidelines on the management of lichen planus: a cooperation of the European Dermatology Forum with the European Academy of Dermatology and VenereologyD Ioannides, E Vakirlis, L Kemeny, et al.
Pageof 57

Showing results (551-560 of 564) with videos related to

Sort By:
Pageof 57
The British Journal of Dermatology|August 18, 2009
A randomized controlled trial of R-salbutamol for topical treatment of discoid lupus erythematosusG B E Jemec, S Ullman, M Goodfield, et al.
American Journal of Human Genetics|June 23, 1998
Muir-Torre phenotype has a frequency of DNA mismatch-repair-gene mutations similar to that in hereditary nonpolyposis colorectal cancer families defined by the Amsterdam criteriaR Kruse, A Rütten, C Lamberti, et al.
The British Journal of Dermatology|March 13, 2010
Systematic mutation screening of KRT5 supports the hypothesis that Galli-Galli disease is a variant of Dowling-Degos diseaseS Hanneken, A Rütten, S M Pasternack, et al.
The British Journal of Dermatology|November 30, 2018
Association of pyrin mutations and autoinflammation with complex phenotype hidradenitis suppurativa: a case-control studyS Vural, M Gündoğdu, E Gökpınar İli, et al.
The Journal of Investigative Dermatology|December 14, 1999
Novel Hairless mutations in two kindreds with autosomal recessive papular atrichiaR Kruse, S Cichon, M Anker, et al.
Arthritis and Rheumatism|May 29, 2007
Low number of regulatory T cells in skin lesions of patients with cutaneous lupus erythematosusB Franz, B Fritzsching, A Riehl, et al.
The British Journal of Dermatology|October 13, 2006
Multicentre, phase II trial on the safety and efficacy of topical tacrolimus ointment for the treatment of lichen sclerosusU R Hengge, W Krause, H Hofmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2000
Cutting edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ALP/ILC)B Homey, W Wang, H Soto, et al.
The British Journal of Dermatology|September 27, 2015
The first trial of CIM331, a humanized antihuman interleukin-31 receptor A antibody, in healthy volunteers and patients with atopic dermatitis to evaluate safety, tolerability and pharmacokinetics of a single dose in a randomized, double-blind, placebo-controlled studyO Nemoto, M Furue, H Nakagawa, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 18, 2020
European S1 guidelines on the management of lichen planus: a cooperation of the European Dermatology Forum with the European Academy of Dermatology and VenereologyD Ioannides, E Vakirlis, L Kemeny, et al.
Pageof 57